Why the study?
Does low-dose fibrinolysis during primary percutaneous intervention prevent no-reflow?
Does low-dose fibrinolysis during primary percutaneous intervention prevent no-reflow?
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pelliccia et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: